8-K: HeartCore Enterprises Announces Record Preliminary Q3 2024 Results, Fueled by Go IPO Success

HeartCore Enterprises reports preliminary Q3 2024 revenue and net income significantly exceeding prior year figures, driven by a successful Go IPO deal and increased software licensing.

Summary

• HeartCore Enterprises has released preliminary financial results for the third quarter of 2024, showing substantial growth.
• The company expects Q3 2024 revenues to be between $17 million and $19 million, a 263% to 305% increase compared to $4.7 million in the same quarter last year.
• Revenues for the nine months ended September 30, 2024, are projected to be between $26 million and $28 million, a 40% to 51% increase from $18.5 million in the same period last year.
• Net income for Q3 2024 is expected to be between $9 million and $11 million, a significant turnaround from a $2.5 million net loss in the same period last year.
• Net income for the nine months ended September 30, 2024, is expected to be between $5 million and $7 million, compared to a net loss of $1.8 million in the same period last year.
• The Software Related Business is expected to generate $4 million in revenue, while the Go IPO Business is expected to generate between $13 million and $15 million in revenue for Q3 2024.
• A significant portion of the Go IPO revenue, approximately $12 to $14 million, is attributed to warrants from the recent public listing of SBC Medical Group Holdings Incorporated.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to the significant revenue and profit growth, successful IPO deal, and optimistic future outlook. The language used by management is also very positive.

Positives

• The company achieved its strongest quarter in history in Q3 2024.
• The significant revenue increase is primarily due to the successful public listing of a Go IPO client, SBC Medical Group Holdings Incorporated.
• HeartCore has an additional three Go IPO deals slated to close in the coming months, which are expected to further strengthen financial results.
• The shift towards multi-year software licensing agreements has positively impacted the Software Related Business revenues.
• The company is optimistic about the U.S. IPO market for Japanese companies.

Risks

• The reported financial results are preliminary and unaudited, and are subject to change during the final quarterly review process.
• The company's future performance is subject to risks and uncertainties, as detailed in their filings with the Securities and Exchange Commission.
• The company's forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The company anticipates continued growth and expects 2024 to be its strongest year, with additional Go IPO deals expected to close in the coming months. They are committed to maintaining this upward trend for future quarters and years.

Management Comments

• The Company CEO Sumitaka Kanno stated that the third quarter was the strongest in HeartCore's history.
• The CEO attributed the significant increase to the recent public listing of their Go IPO client, SBC Medical Group Holdings Incorporated.
• The CEO mentioned that the company has an incremental three Go IPO deals that are slated to close over the next several months.
• The CEO noted that the company shifted toward proposing multi-year software licensing agreements to customers starting in 2024.

Industry Context

This announcement highlights the growing demand for IPO consulting services and enterprise software solutions, particularly in the Japanese market. HeartCore's success with the SBC Medical Group Holdings Incorporated IPO positions them as a key player in this space.

Comparison to Industry Standards

• While specific competitor data is not provided in the document, the revenue growth of 263% to 305% year-over-year in Q3 2024 is significantly higher than typical growth rates for established software and consulting companies.
• The net income turnaround from a loss of $2.5 million to a profit of $9 million to $11 million in Q3 2024 is also a substantial improvement, suggesting strong operational performance.
• The success of the Go IPO business, particularly the $12 to $14 million in revenue from warrants, indicates a unique and potentially lucrative business model compared to traditional consulting firms.
• Companies like Salesforce and SAP, which are leaders in the enterprise software space, typically see more moderate growth rates, making HeartCore's performance stand out.

Stakeholder Impact

• Shareholders are likely to react positively to the strong financial results and positive outlook.
• Employees may benefit from the company's growth and success.
• Customers may see improved services and product offerings due to the company's increased resources.
• Suppliers and creditors may view the company as a more stable and reliable partner.

Next Steps

• The company will provide full details of their third quarter 2024 financial results in mid-November.
• The company expects to close three additional Go IPO deals in the coming months.

Key Dates

Keywords

Go IPO, Software as a Service, SaaS, Financial Results, Net Income, Revenue, Software Licensing, Consulting Services, Digital Transformation, Customer Experience Management